Inventor · disambiguated record
Vu Hong
Also filed as: HONG VU · HONG VU PHONG
5 granted patents·14 pending applications·5 citations·filing 2013–2025
68Inventor score
Top patents by PatentIndex Score
19 records- 0181US10287564B2Procoagulant compoundsBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted May 14, 2019·5 cites·11 claims
- 0273US2025248995A1Compositions and methods for treating polycythemiaDISC MEDICINE INC·Filed 2024·Application pending·0 cites
- 0371US2024269132A1Compositions and methods for treating polycythemiaDISC MEDICINE INC·Filed 2024·Application pending·0 cites
- 0471US2025262204A1Methods of treating erythropoietic protoporphyria, x-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitorsDISC MEDICINE INC·Filed 2024·Application pending·0 cites
- 0568US2022135959A1Chimeric clotting factorsBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0666US11261437B2Procoagulant compoundsBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Mar 1, 2022·0 cites·12 claims
- 0765US11168316B2Chimeric clotting factorsBIOVERATIV THERAPEUTICS INC·Filed 2018·Granted Nov 9, 2021·0 cites·12 claims
- 0864US2024400553A1Amine based matriptase 2 inhibitors and uses thereofDISC MEDICINE INC·Filed 2024·Application pending·0 cites
- 0963US11813257B2Methods of treating erythropoietic protoporphyria, X-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitorsDISC MEDICINE INC·Filed 2021·Granted Nov 14, 2023·0 cites·23 claims
- 1062US2024366574A1Methods of treating erythropoietic protoporphyria, x-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitorsDISC MEDICINE INC·Filed 2022·Application pending·0 cites
- 1158US2025228827A1Methods of treating erythropoietic protoporphyria, x-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitorsDISC MEDICINE INC·Filed 2025·Application pending·0 cites
- 1257US2022243189A1Procoagulant compoundsBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1356US2025197844A1Methods and compositions for targeted delivery of intracellular biologicsTRAVIN BIO INC·Filed 2023·Application pending·0 cites
- 1456US2025302823A1Compositions and methods for treating hepatic porphyrias with glycine transport inhibitorsDISC MEDICINE INC·Filed 2023·Application pending·0 cites
- 1554US2024390362A1Methods of treating erythropoietic protoporphyria, x-linked protoporphyria, or congenital erythropoietic porphyria with a solid form of bitopertinDISC MEDICINE INC·Filed 2022·Application pending·0 cites
- 1653US2023348454A1Compounds as modulators of bis-phosphoglycerate mutase for the treatment of sickle cell diseaseGENZYME CORP·Filed 2021·Application pending·0 cites
- 1753US2023348450A1Carboxylic acid-containing compounds as modulators of bis-phosphoglycerate mutase for the treatment of sickle cell diseaseGENZYME CORP·Filed 2021·Application pending·0 cites
- 1852US10202595B2Chimeric clotting factorsBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted Feb 12, 2019·0 cites·14 claims
- 1952US2024317801A1Peptidomimetic matriptase 2 inhibitors and uses thereofDISC MEDICINE INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vu Hong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →